Synresta Tablets 250mg, containing Probucol (YJ code: 2189008F1376, standard: 250mg x 1 tablet) from Alfresa Pharma, is a lipid-lowering agent primarily used to treat hypercholesterolemia, including familial hypercholesterolemia and xanthoma, by increasing LDL catabolism and inhibiting cholesterol synthesis.
Synresta Tablets 250mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
